Lucas Canto-de-Souza

Dr. Lucas Canto-de-Souza

School of Pharmaceutical Sciences, University of São Paulo State (UNESP), Araraquara, São Paulo, Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TRTais de Cassia Ribeiro
Tais de Cassia Ribeiro
RSRafael Miguel Sábio
Rafael Miguel Sábio
MLMarcela Tavares Luiz
Marcela Tavares Luiz
Lucas Canto-de-SouzaLucas Canto-de-Souza
Lucas Canto-de-Souza
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive and behavioral impairment. Curcumin-loaded mesoporous silica nanoparticles (MSN-CCM) can overcome the drawbacks related to the free curcumin (CCM) clinical application, such as water insolubility and low bioavailability, besides acting over the main causes associated to AD. A thermo-responsive hydrogel is an interesting approach for facilitating the administration of the nanosystem via a nasal route, as well as for overcoming mucociliary clearance mechanisms. In light of this, MSN-CCM were dispersed in the hydrogel and evaluated through in vitro and in vivo assays. The MSNs and MSN-CCM were successfully characterized by physicochemical analysis and a high value of the CCM encapsulation efficiency (EE%, 87.70 ± 0.05) was achieved. The designed thermo-responsive hydrogel (HG) was characterized by rheology, texture profile analysis, and ex vivo mucoadhesion, showing excellent mechanical and mucoadhesive properties. Ex vivo permeation studies of MSN-CCM and HG@MSN-CCM showed high permeation values (12.46 ± 1.08 and 28.40 ± 1.88 μg cm−2 of CCM, respectively) in porcine nasal mucosa. In vivo studies performed in a streptozotocin-induced AD model confirmed that HG@MSN-CCM reverted the cognitive deficit in mice, acting as a potential formulation in the treatment of AD.

1 May 2017 in Neuropharmacology
Verified
Journal Article
Closed access
Lucas Canto-de-SouzaLucas Canto-de-Souza
Lucas Canto-de-Souza
GPGustavo Provensi
Gustavo Provensi
DVDaniela Vullo
Daniela Vullo
FCFabrizio Carta
Fabrizio Carta
ASAndrea Scozzafava
Andrea Scozzafava
PBPatrizio Blandina
Patrizio Blandina

12 June 2023 in Frontiers in Integrative Neuroscience
Verified
Journal Article
Open access
VCVinícius Fresca da Costa
Vinícius Fresca da Costa
JRJohana Caterin Caipa Ramírez
Johana Caterin Caipa Ramírez
SRStephany Viatela Ramírez
Stephany Viatela Ramírez
JAJulian Humberto Avalo-Zuluaga
Julian Humberto Avalo-Zuluaga
DBDaniela Baptista-De-Souza
Daniela Baptista-De-Souza
RNRicardo Luiz Nunes-De-Souza
Ricardo Luiz Nunes-De-Souza
Introduction: Chronic exposure to social defeat stress (SDS) has been used to investigate the neurobiology of depressive- and anxiety-like responses and mnemonic processes. We hypothesized that these affective, emotional, and cognitive consequences induced by SDS are regulated via glutamatergic neurons located in the bed nucleus of the stria terminalis (BNST), amygdaloid complex, and hippocampus in mice.Methods: Here, we investigated the influence of chronic SDS on (i) the avoidance behavior assessed in the social interaction test, (ii) the anxiety-like behavior (e.g., elevated plus-maze, and open field tests) (iii) depressive-like behaviors (e.g., coat state, sucrose splash, nesting building, and novel object exploration tests), (iv) the short-term memory (object recognition test), (v) ΔFosB, CaMKII as well as ΔFosB + CaMKII labeling in neurons located in the BNST, amygdaloid complex, dorsal (dHPC) and the ventral (vHPC) hippocampus.Results: The main results showed that the exposure of mice to SDS (a) increased defensive and anxiety-like behaviors and led to memory impairment without eliciting clear depressive-like or anhedonic effects; (b) increased ΔFosB + CaMKII labeling in BNST and amygdala, suggesting that both areas are strongly involved in the modulation of this type of stress; and produced opposite effects on neuronal activation in the vHPC and dHPC, i.e., increasing and decreasing, respectively, ΔFosB labeling. The effects of SDS on the hippocampus suggest that the vHPC is likely related to the increase of defensive- and anxiety-related behaviors, whereas the dHPC seems to modulate the memory impairment.Discussion: Present findings add to a growing body of evidence indicating the involvement of glutamatergic neurotransmission in the circuits that modulate emotional and cognitive consequences induced by social defeat stress.

1 February 2022 in Neuropharmacology
Verified
Journal Article
Closed access
DBDaniela Baptista-De-Souza
Daniela Baptista-De-Souza
LTLígia Renata Rodrigues Tavares
Lígia Renata Rodrigues Tavares
Lucas Canto-de-SouzaLucas Canto-de-Souza
Lucas Canto-de-Souza
RNRicardo Luiz Nunes-De-Souza
Ricardo Luiz Nunes-De-Souza
ACAzair Canto-De-Souza
Azair Canto-De-Souza


20 December 2021 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
Lucas Canto-de-SouzaLucas Canto-de-Souza
Lucas Canto-de-Souza
PDPeyton G. Demetrovich
Peyton G. Demetrovich
SPSamantha Plas
Samantha Plas
RSRimenez R. Souza
Rimenez R. Souza
JEJoseph Epperson
Joseph Epperson
CMChrista K. McIntyre
Christa K. McIntyre
Post-traumatic stress disorder (PTSD) is associated with decreased activity in the prefrontal cortex. PTSD-like pathophysiology and behaviors have been observed in rodents exposed to a single prolonged stress (SPS) procedure. When animals are left alone for 7 days after SPS treatment, they show increased anxiety-like behavior and impaired extinction of conditioned fear, and reduced activity in the prefrontal cortex. Here, we tested the hypothesis that daily optogenetic stimulation of the infralimbic region (IL) of the medial prefrontal cortex (mPFC) during the 7 days after SPS would reverse SPS effects on anxiety and fear extinction. Male Sprague-Dawley rats underwent SPS and then received daily optogenetic stimulation (20 Hz, 2 s trains, every 10 s for 15 min/day) of glutamatergic neurons of the left or right IL for seven days. After this incubation period, rats were tested in the elevated plus-maze (EPM). Twenty-four hours after the EPM test, rats underwent auditory fear conditioning (AFC), extinction training and a retention test. SPS increased anxiety-like behavior in the EPM task and produced a profound impairment in extinction of AFC. Optogenetic stimulation of the left IL, but not right, during the 7-day incubation period reversed the extinction impairment. Optogenetic stimulation did not reverse the increased anxiety-like behavior, suggesting that the extinction effects are not due to a treatment-induced reduction in anxiety. Results indicate that increased activity of the left IL after traumatic experiences can prevent development of extinction impairments. These findings suggest that non-invasive brain stimulation may be a useful tool for preventing maladaptive responses to trauma.